Results 191 to 197 of about 7,732 (197)
Some of the next articles are maybe not open access.
Downregulation of CD155 (PVR) by mouse cytomegalovirus
2011NK cells are equipped with a collection of activating and inhibitory receptors and thus, the NK activation status depends on the summation of their activating and inhibitory signals. Human CD155 (polio virus receptor, PVR), which is expressed by numerous tumors and healthy cells, is recognized by three different receptors: two co-stimulating receptors (
Babić Čač, Marina +1 more
openaire
CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy
Current Medicinal ChemistryAbstract: Immune checkpoint inhibitors (ICIs) have shown unprecedented efficacy in treating many advanced cancers. Although FDA-approved ICIs have shown promising efficacy in treating many advanced cancers, their application is greatly limited by the low response rate, immune-related adverse events (irAE), and drug resistance.
Yeteng Mu, Xingang Guan
openaire +2 more sources
CD155 Is a Potential Biomarker in Basal Cell Carcinoma
The American Journal of Dermatopathology, 2023Jesús Iván, Martínez-Ortega +2 more
openaire +2 more sources
Clinical significance of CD155 expression in human pancreatic cancer.
Anticancer research, 2015CD155 is expressed in many types of human cells and has diverse functions. We herein evaluated the clinical importance of CD155 in pancreatic cancer.We investigated CD155 expression in 134 patients with pancreatic cancer, and evaluated the correlations of CD155 with prognosis, tumor immunity and angiogenesis.
Satoshi, Nishiwada +9 more
openaire +1 more source
Soluble Isoform of CD155 Is Elevated in Basal Cell Carcinoma
The American Journal of DermatopathologyJesus Ivan Martinez-Ortega +2 more
openaire +2 more sources
CD155/Necl-5 immunolocalization in melanocytic skin lesions
2009F. DAMICO +7 more
openaire +1 more source
CD155/Neel-5 immunolocallization in melanocytic skin lesions
2009D'Amico F +7 more
openaire +1 more source